pyrazines has been researched along with Bilirubinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imagawa, J; Kimura, A; Kinoshita, M; Mihara, K; Mino, T; Sakai, A; Yoshida, T | 1 |
| Harvey, RD; Kaufman, JL; Surati, M; Walker, BF; Wilson, N | 1 |
2 other study(ies) available for pyrazines and Bilirubinemia
| Article | Year |
|---|---|
[Successful treatment with bortezomib for a patient with plasma cell leukemia accompanied by severe hyperbilirubinemia].
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Therapy, Combination; Female; Humans; Hyperbilirubinemia; Leukemia, Plasma Cell; Prednisolone; Pyrazines; Severity of Illness Index; Treatment Outcome | 2012 |
Bortezomib administration with severe hyperbilirubinemia caused by hepatic plasma cell infiltration: a case report.
Topics: Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Female; Humans; Hyperbilirubinemia; Liver; Middle Aged; Multiple Myeloma; Plasma Cells; Pyrazines | 2013 |